High Throughput Process Development Market to Reach US$ 17 Bn by 2029
Adoption of miniaturized bioreactors is a growing trend, replacing conventional bioreactor systems in the life sciences industry. The introduction of miniaturized, disposable bioreactors, and micro platforms is boosting the adoption of such devices for the production and testing of new pharmaceutical products. High throughput miniaturized bioreactor systems decrease the time for cell culture process development, thereby accelerating biopharmaceutical development. For instance, Advanced Microscale Bioreactors is an automated microbioreactor system coupled with miniature single use bioreactors that delivers higher volume. With an established biopharmaceutical industry, North America leads the global high throughput process development market. Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/31236 The global high throughput process development market is projected to exhibit a CAGR of 9% over the forecast perio...